
Neurocrine Biosciences, Inc.
USD170.00
+1.48 (+0.88%)
CEO
Kyle W. Gano
IPO Date
1996-05-23
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$168.83
Prev. Close
$168.52
Day Low
$168.83
Day High
$171.43
52W Low
$122.14
52W High
$171.43
Market Cap
$17.09B
Volume
1.35M
| 6 May 2026 |
| Wedbush |
| Outperform |
| Outperform |
| maintain |
| 6 May 2026 | Guggenheim | Buy | Buy | maintain |
| 6 May 2026 | Piper Sandler | Overweight | Overweight | maintain |
| 6 May 2026 | RBC Capital | Outperform | Outperform | maintain |
| 6 May 2026 | Morgan Stanley | Equal Weight | Equal Weight | maintain |
| 6 May 2026 | Citigroup | Buy | Buy | maintain |
| 22 Apr 2026 | Leerink Partners | Outperform | Outperform | maintain |